Drug Shortage Report for HAVRIX 720 JUNIOR

Last updated on 2024-02-23 History
Report ID 220335
Drug Identification Number 02231056
Brand name HAVRIX 720 JUNIOR
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s)
Strength(s) 720UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-02-21
Estimated end date 2024-05-17
Actual end date
Shortage status Actual shortage
Updated date 2024-02-23
Company comments Supply available for public programs. Supply unavailable in the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-02-23 French Compare
v1 2024-02-23 English Compare

Showing 1 to 2 of 2